1. Home
  2. RXO vs TLX Comparison

RXO vs TLX Comparison

Compare RXO & TLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo RXO Inc.

RXO

RXO Inc.

N/A

Current Price

$28.45

Market Cap

4.0B

Sector

N/A

ML Signal

N/A

Logo Telix Pharmaceuticals Limited American Depositary Shares

TLX

Telix Pharmaceuticals Limited American Depositary Shares

N/A

Current Price

$8.40

Market Cap

3.3B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
RXO
TLX
Founded
2022
2015
Country
United States
Australia
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.0B
3.3B
IPO Year
2022
2024

Fundamental Metrics

Financial Performance
Metric
RXO
TLX
Price
$28.45
$8.40
Analyst Decision
Hold
Strong Buy
Analyst Count
18
5
Target Price
★ $29.83
$19.66
AVG Volume (30 Days)
★ 3.4M
281.5K
Earning Date
10-29-2026
02-18-2027
Dividend Yield
N/A
N/A
EPS Growth
★ 72.81
N/A
EPS
N/A
★ N/A
Revenue
★ $5,742,000,000.00
N/A
Revenue This Year
$21.30
$16.83
Revenue Next Year
$10.66
$13.81
P/E Ratio
★ N/A
$150.33
Revenue Growth
★ 26.20
N/A
52 Week Low
$11.18
$6.28
52 Week High
$29.90
$13.11

Technical Indicators

Market Signals
Indicator
RXO
TLX
Relative Strength Index (RSI) 58.68 33.74
Support Level $28.14 $6.28
Resistance Level $28.68 $9.83
Average True Range (ATR) 0.43 0.25
MACD -0.13 -0.03
Stochastic Oscillator 63.48 0.95

Price Performance

Historical Comparison
RXO
TLX

About RXO RXO Inc.

RXO Inc is a brokered transportation platform defined by technology and a nimble, asset-light business model, with the component being core truck brokerage business. Its operations also include three asset-light, brokered transportation services, all of which complement its truck brokerage business: managed transportation, last mile and freight forwarding. The company operates into one reportable segment. The operates within the transportation industry and in the same geography North America.

About TLX Telix Pharmaceuticals Limited American Depositary Shares

Telix is a developer of radiopharmaceuticals. Radiopharmaceuticals are specialized drugs containing radioactive isotopes, which are used in both diagnosing and treating cancer. At low doses, these drugs bind to a specific cancer cell and can be visualized through PET imaging. With high doses, they can deliver targeted treatment. Telix has a pipeline of both diagnostics and therapeutics in development. Its pipeline is focused on urologic oncology (prostate, kidney and bladder), neuro-oncology (glioma), musculoskeletal oncology and hematology. Currently, most of the firm's revenue comes from its Illuccix prostate cancer imaging/diagnostic agent.

Share on Social Networks: